GlaxoSmithKline has presented details of 20 potential blockbusters in its pipeline which it claims could bring it industry leading growth …
Merck and Schering-Plough have indicated that efficacy and not safety will be the focus of their up-and-coming cholesterol combination drug.Merck …
New guidance advising doctors not to use hormone replacement therapy to treat osteoporosis has prompted the resignation of a senior …
The head of the new independent watchdog to monitor NHS foundation trusts has been named as Bill Moyes, current Director-General …
A fundamental change is underway in the European healthcare sector. The traditional autonomy of the physician has yielded to more …
Sometimes it is hard to see where the fun lies in running a biotechnology company. Discounting the obvious success stories …
MEPs have put forward new proposals to provide patients and the public with greater information on medicines, in an attempt …
A European Union safety review of the COX-II inhibitor class of drugs has recommended stronger labelling for painkiller treatments for …
America’s long-awaited reform of the Medicare health insurance system has received the backing of both Houses of government, giving over …
The World Health Organisation has called for massively increased efforts to distribute antiretrovirals in the developing world to cut unnecessary …
Red Door Communications has scooped several top prizes at the prestigious PR Week Awards including one for its hepatitis B …
Novartis has unveiled details of major new drugs in its pipeline which it says could produce annual sales of $10 …
The FDA has claimed a significant victory in its battle against imports of prescription medicines from Canada after a court …
The chief US medicines regulator has attacked price controls in Europe, saying the practice denies its patients access to medicines …
The Government has declared its strong backing for statins to be made available to consumers over the counter as early …